1 Stock to Buy, 1 Stock to Sell This Week: Lululemon, Pfizer

Looking for more actionable trade ideas to navigate the current market volatility? Members of InvestingPro get exclusive ideas and guidance to navigate any climate.Stocks on Wall Street ended mostly lower on Friday to wrap up a volatile week, as a spike in oil prices and rising inflation expectations soured investors on riskier bets.The week ahead is expected to be another busy one as investors continue to assess the outlook for the economy, inflation, interest rates and corporate earnings.

S&P Dow Jones Indices said late Friday that the Vancouver-based athletic apparel maker will join the widely followed index - which tracks the stock performance of 500 of the largest companies listed on the U.S. stock market - before the start of trading on Wednesday, October 18.History has shown that stocks often enjoy a boost after the announcement of their addition to the S&P 500.

Shares are up 17.9% year-to-date, much better than the 3% decline recorded by the SPDR® S&P Retail ETF stock will suffer a challenging week ahead, with a potential drop to new 52-week lows on the horizon, as investors react to fresh negative developments plaguing one of the world’s largest pharmaceutical companies.

The views discussed in this article are solely the opinion of the author and should not be taken as investment advice.Q3 earnings season unofficially kicks off on Friday, October 13, when the big banks report their latest results. Analysts expect a 0.3% yearly profit decline and an increase of...

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Lululemon's stock to join S&P 500 indexElectrical company Hubbell also joining the S&P
Source: MarketWatch - 🏆 3. / 97 Read more »

Pfizer stock sinks as pharma giant cuts earnings outlook on weaker COVID demandModerna, Novavax shares also pressured after hours
Source: MarketWatch - 🏆 3. / 97 Read more »

Pfizer’s stock sinks after company cuts outlook on lower demand for COVID productsWallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.
Source: MarketWatch - 🏆 3. / 97 Read more »